- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | MANGOCEUTICALS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 09.10. | Mangoceuticals sichert sich 500.000 US-Dollar durch Direktplatzierung | 2 | Investing.com Deutsch | ||
| 09.10. | Mangoceuticals, Inc.: Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close | 1 | GlobeNewswire (USA) | ||
| 09.10. | MANGOCEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.10. | Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why | 1 | Benzinga.com | ||
| 01.10. | Mangoceuticals-Tochter sichert sich 2,5-Millionen-Dollar-Investment | 1 | Investing.com Deutsch | ||
| 01.10. | Mangoceuticals, Inc.: Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche | 199 | GlobeNewswire (Europe) | Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026... ► Artikel lesen | |
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 01.10. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 06.08. | Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why | 1 | Benzinga.com | ||
| 04.08. | Mangoceuticals, Inc.: Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination | 237 | GlobeNewswire (Europe) | Dallas, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") today announced it has received an additional 180-calendar-day extension from... ► Artikel lesen | |
| 03.08. | Nuclea Energy To Go Public Through Mangoceuticals Combination With Former Shareholders Owning About 96% | 2 | pulse2.com | ||
| 30.07. | Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor | 929 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing... ► Artikel lesen | |
| 30.07. | Mangoceuticals agrees to merge with nuclear microreactor developer | 6 | Investing.com | ||
| 30.07. | Mangoceuticals kündigt Fusion mit Nukleartechnik-Unternehmen Nuclea an | 4 | Investing.com Deutsch | ||
| 30.07. | Mangoceuticals, Inc.: Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology | 6.973 | GlobeNewswire (Europe) | Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Markets Amid Surging Power Demand from AI and Data Centers DALLAS, TEXAS, July 30, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 30.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 10.07. | MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 02.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,089 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| NUWELLIS, INC | 4,580 | 0,00 % | Nuwellis submits FDA application for pediatric Aquadex expansion | ||
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| ENVUE MEDICAL | 3,400 | 0,00 % | ENvue Medical Commences U.S. Production of UroShield and Begins Fulfilling UK Distributor Orders | Shipments to Peak Medical underway under agreement with multi-million-dollar minimum purchase commitments through 2029; follows September start of PainShield shipments in the U.S. ARLINGTON HEIGHTS... ► Artikel lesen | |
| AGAPE ATP | 1,250 | 0,00 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS | 52,48 | +1,18 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius und WuXi Biologics schließen exklusive Entwicklungsvereinbarung zum Ausbau der Biosimilars-Pipeline | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Vereinbarung
Fresenius und WuXi Biologics schließen exklusive Entwicklungsvereinbarung zum Ausbau der Biosimilars-Pipeline ... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,660 | +0,22 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,230 | -0,21 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung gemäß § 50 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Drittstaatveröffentlichung nach § 50 Abs. 1, Nr. 2 WpHG
Fresenius Medical Care AG: Veröffentlichung gemäß §... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,610 | -0,28 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| PRIVIA HEALTH GROUP | 24,420 | 0,00 % | Privia Health Group, Inc. - 10-Q, Quarterly Report | ||
| BRIGHTSPRING HEALTH SERVICES | 67,13 | -0,03 % | Guggenheim raises BrightSpring Health stock price target on growth | ||
| BILLIONTOONE | 114,01 | +0,06 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target | ||
| LIFESTANCE HEALTH GROUP | 13,770 | 0,00 % | BMO raises Lifestance Health stock price target on strong results | ||
| GENEDX | 62,28 | -0,14 % | GeneDx partners with Mirum for free genetic testing program |
MANGOCEUTICALS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,200 Euro und damit +2,67 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MANGOCEUTICALS INC finden Sie auf Wallstreet Online.